NCT00702195View on ClinicalTrials.gov

Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2002

Primary Completion Date

September 15, 2003

Study Completion Date

September 15, 2003

Conditions

Pregnancy

Interventions

DRUG

Org 36286 (corifollitropin alfa)

single dose of Org 36286 (corifollitropin alfa) administered under protocol 38805/38807

DRUG

Placebo

single dose of placebo (administered under protocol 38805)

DRUG

recFSH

150 IU recFSH daily (reference group administered under protocol 38807)

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00702195 - Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED) | Biotech Hunter | Biotech Hunter